Landscapes / Targets

TTR

8 drugs act on TTR, in 19 active trials · Any stage · updated 18 Nov 2026

FollowEvery change as it happens, and a Monday email

Drugs8

DrugHow it worksCompanyStageNext dateDetails
Transthyretin stabilizer
Approved in the EU 17 Sep 2027Phase 4 trial completes
Small interfering RNA
Alnylam · Public ALNY
Approved 27 Dec 2027Phase 3 trial completes
Transthyretin stabilizer
Approved in Japan 31 Mar 2028Phase 4 trial completes
Transthyretin stabilizer
Approved 15 Apr 2028Phase 3 trial completes
Transthyretin-directed RNA Interaction; antisense oligonucleotide
Ionis Pharmaceuticals +1 · Public AZN
Approved 6 Feb 2029Phase 2 trial completes
—
Phase 3 Jul 2027Phase 3 trial completes
—
Phase 3 6 Dec 2027Phase 3 trial completes
Small interfering RNA
Alnylam · Public ALNY
Phase 3 27 Dec 2027Phase 3 trial completes

About this list

Checked
8 of 8 drugs. How we check
Matches
The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
Sources
ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow TTR

Following is part of Solo: you see every change to TTR the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in